A new research paper titled "Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention" has been published in Oncotarget. Cancer treatment ...

Revvity, Inc. RVTY announced the launch of the in-vitro diagnostic EURORealTime APOE assay in European countries that accept the CE mark on Oct. 2. The assay will likely enable accurate genotyping of ...

Fiber intake is associated with a lower risk of developing cognitive decline in those old people with the Apolipoprotein E ApoE ε4 genotype, regarded as a genetic risk factor linked to the development ...

Apolipoprotein E (APOE) genotyping has become a cornerstone in the evaluation of individual susceptibility to Alzheimer disease (AD). Three common alleles—ε2, ε3 and ε4—encode protein isoforms that ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), announced today the launch of the in-vitro diagnostic EURORealTime TM APOE assay in European countries that accept the CE mark, which will ...

Older adults who took vitamin D supplements developed dementia at roughly 40 percent lower rates than those who did not, according to a prospective study of 12,388 dementia-free participants tracked ...

Apolipoprotein E (APOE) is a lipid-transport protein with three common isoforms—ε2, ε3 and ε4—that modulate neuronal repair, inflammation and amyloid metabolism. The ε4 allele is the strongest genetic ...

The APOE gene—coding for a protein involved in lipid transport and implicated in the clearance of amyloid-beta, one of the proteins that builds up in the brain in Alzheimer's disease—exists in three ...

In a recent study published in Nature, researchers investigated the relationship between apolipoprotein E (APOE4) genotype and coronavirus disease 2019 (COVID-19) outcomes using genetic models of mice ...

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s “With the introduction of new disease-modifying drugs for treating Alzheimer’s, ...